Table 1:
Details of the included studies
First author | Year | Country | Study period | Age (Mean ± SD) | Intervention details | Carrier for essential oil | Participants details | Outcome measurements | Design of the study |
---|---|---|---|---|---|---|---|---|---|
Pam Conrad, | 2012 | USA | Twice a week/4 weeks | 32 ± 4.4 | Inhalation of Lavender essential oil with 2% rose otto blend. | Inhalation- Jojoba oil; Hand m’ technique - Unscented white lotion. | 28 Women, 0–18 Months of Postpartum. | EPDS, and GAD | RCT |
Kianpour M, | 2018 | Iran | Daily/6 weeks | 1.23 ± 1.04 | Inhalation of 7 drops of Lavender Essential oil and 1cc Rose water, before sleep. | Rosewater | 105 - pregnant women from 37 weeks | EPDS, HADS and NSSQ | RCT |
Kianpour M, | 2016 | Iran | 3 times per day/4 weeks | not specified | Inhalation 3 drops of Lavender essential oil | Nil | 140 women after child birth. | EPDS, DASS-21 | RCT |
Mirghafourvand, | 2016 | Iran | 3 times per day/8 weeks | 28.8 ± 5.3 | Participants drank a glass of water with 10 drops of orange peel essential oil | Drinking water | 96 non-depressed women | EPDS, and STAI | RCT |